Mitsubishi Tanabe Pharma buys Neuroderm for $1.1 billion
Japanese pharmaceutical giant to acquire Israel’s Neuroderm in record breaking deal
Japanese company Mitsubishi Tanabe Pharma (MTPC) has agreed to purchase the Israeli pharmaceutical firm Neuroderm for $1.1 billion (£0.8 billion) in cash.